Kedar E, Schwartzbach M, Klein E
Eur J Cancer Clin Oncol. 1982 Sep;18(9):861-5. doi: 10.1016/0277-5379(82)90196-1.
Splenocytes of A(H-2a), BALB/c(H-2d) and C57BL/6(H-2b) mice that were sensitized against several allogeneic normal lymphocytes and lymphoma cells in mixed lymphocyte cultures (MLC) and mixed lymphocyte-tumor cell cultures (MLTC) exhibited the expected cell-mediated cytotoxic responses against normal and tumor cells carrying the relevant alloantigens. In contrast, strong cytotoxic reactivity cross-reactive with C57BL/6 target cells was observed when a variant of YAC lymphoma (YAC-b) of strain A mice were employed either as sensitizers or as targets. Furthermore, this 'unpredicted' cross-reactivity was also obtained with syngeneic responder splenocytes sensitized to YAC-b cells. The possibility that the nonspecific cytotoxicity was caused by activation of natural killer (NK) cells in the culture was excluded by the finding that the cytotoxic capability of sensitized effector cells was greatly diminished by treatment with anti-Thy 1.2 serum and complement. Serologic analysis with anti-H-2 alloantisera revealed that the YAC-b tumor line, but not the parental YAC lymphoma, carried H-2b alloantigens. It is concluded that the 'unpredicted' cytotoxic responses here observed is a result of conventional antigen recognition and of specific sensitization to alien H-2b components expressed on the YAC-b subline.
在混合淋巴细胞培养(MLC)和混合淋巴细胞-肿瘤细胞培养(MLTC)中对几种同种异体正常淋巴细胞和淋巴瘤细胞致敏的A(H-2a)、BALB/c(H-2d)和C57BL/6(H-2b)小鼠的脾细胞,对携带相关同种异体抗原的正常细胞和肿瘤细胞表现出预期的细胞介导的细胞毒性反应。相比之下,当使用A系小鼠的YAC淋巴瘤变体(YAC-b)作为致敏剂或靶细胞时,观察到与C57BL/6靶细胞有强烈交叉反应的细胞毒性反应。此外,用对YAC-b细胞致敏的同基因反应性脾细胞也获得了这种“意外的”交叉反应性。致敏效应细胞的细胞毒性能力在用抗Thy 1.2血清和补体处理后大大降低,这一发现排除了培养物中自然杀伤(NK)细胞激活导致非特异性细胞毒性的可能性。用抗H-2同种异体抗血清进行的血清学分析表明,YAC-b肿瘤系而非亲本YAC淋巴瘤携带H-2b同种异体抗原。得出的结论是,这里观察到的“意外的”细胞毒性反应是传统抗原识别以及对YAC-b亚系上表达的外来H-2b成分特异性致敏的结果。